Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage McEwen Inc MUX Q1 2026 Earnings EPS Surges Past Estimates Amid Strong Gold Operations Worthington Enterprises WOR Q1 2026 Earnings EPS Slightly Beats Estimates as Stock Gains 11 Immunome Inc Q1 2026 Earnings NarrowerThanExpected Loss Amid No Revenue Stock Slips OMC Q1 2026 Earnings EPS Surpasses Estimates Amid Mixed Market Dynamics Immunome Q1 2026 Earnings EPS Beats Estimates Despite No Revenue Stock Declines